Trinity Biotech plc

NASDAQ:TRIB

Medical - Diagnostics & Research

Healthcare
$5.83 -5.73%

-$0.51 today

Market cap
$117.96M
Beta
1.00
P/E (TTM)
-0.1
EPS (TTM)
-$60.27
52W Low $8.00High $103.20

Volume 0.00M

Average 1.34M

TRIB Other Working Capital

Cash effect of changes in other operating assets and liabilities.

Trinity Biotech plcNASDAQ: TRIB

Other Working Capital · Q4 FY2025 · quarter ended Dec 2025

Other working capital dips below year-ago levels

Q4 FY2025 other working capital of $1.73M fell 73.1% year over year, behind the +57.6% change in trailing-twelve-month other working capital. Sequentially, it rose 213.8% from the prior quarter. Over 3 fiscal years it compounded at -35.6% a year.

Context

  • Other working capital amounted to 4.6% of revenue in FY2025, down 12.1 pp from a year earlier.
  • Other working capital increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -73.1% toward the trailing-twelve-month pace of +57.6%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterDec 2025
$1.73M+213.8% QoQ
Last fiscal yearDec 2025
$2.02M-80.4% YoY
LTMDec 2025
$6.42M+57.6% YoY
Other Working Capital past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-73.1%——
1 year-80.4%——
3-year CAGR-35.6%——
5-year CAGR——
10-year CAGR——

Other Working Capital history

USD · from the cash flow

Latest · FY2025
2.02M USD
Year-over-year change
-80.4%
4-year CAGR
-22.5%

Other Working Capital vs competitors

How TRIB compares with its peers on the latest reported figures

No competitor Other Working Capital figures are available to compare.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income875K(41.01M)(24.02M)(31.79M)(37.38M)
Depreciation & Amortization2.74M2.33M1.78M1.87M2.68M
Deferred Income Tax(167K)(192K)(59K)486K199K
Stock-Based Compensation1.1M1.76M2.07M1.32M324K
Change in Working Capital(172K)(1.66M)(2.69M)6.19M7.03M
Accounts Receivables6.24M(966K)1.05M(2.37M)4.92M
Inventory(4.41M)(877K)(971K)(1.74M)90K
Accounts Payables(7.59M)181K(2.77M)8.19M0
Other Working Capital5.59M7.57M(478K)10.3M2.02M
Other Non-Cash Items8.86M37.85M11.37M17.74M21.21M
Operating Cash Flow13.24M(921K)(11.56M)(4.19M)(5.93M)
Capital Expenditures(8.69M)(5.98M)(803K)(10.06M)(6.22M)
Acquisitions (Net)0028.16M(12.9M)0
Purchases of Investments00(700K)00
Sales of Investments00000
Other Investing Activities(6.88M)(4.88M)(1.9M)(9.66M)(6.14M)
Investing Cash Flow(8.69M)(5.98M)24.76M(22.97M)(6.22M)
Debt Repayment(2.94M)(27.04M)(7.37M)27.67M11.81M
Common Stock Issued025.34M07.39M547K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(3.08M)(10.61M)(8.67M)(6.25M)(308K)
Financing Cash Flow(6.02M)(12.32M)(16.04M)28.81M12.05M
Effect of Forex Changes55K(112K)(44K)(175K)71K
Net Change in Cash(1.42M)(19.33M)(2.89M)1.48M(29K)
Free Cash Flow4.55M(6.9M)(12.36M)(14.26M)(12.15M)

Trinity Biotech plc

NASDAQ:TRIB

Intrinsic Alpha fair value

Locked

Current Price

$5.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.